DE69841804D1 - Diagnoseverfahren - Google Patents

Diagnoseverfahren

Info

Publication number
DE69841804D1
DE69841804D1 DE69841804T DE69841804T DE69841804D1 DE 69841804 D1 DE69841804 D1 DE 69841804D1 DE 69841804 T DE69841804 T DE 69841804T DE 69841804 T DE69841804 T DE 69841804T DE 69841804 D1 DE69841804 D1 DE 69841804D1
Authority
DE
Germany
Prior art keywords
predicting
development
lung damage
damage
diagnosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69841804T
Other languages
English (en)
Inventor
Ian Ross Doyle
Andrew David Bersten
Terence Evan Nicholas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southern Medical Diagnostics Pty Ltd
Original Assignee
Southern Medical Diagnostics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO8999A external-priority patent/AUPO899997A0/en
Priority claimed from AUPP5062A external-priority patent/AUPP506298A0/en
Application filed by Southern Medical Diagnostics Pty Ltd filed Critical Southern Medical Diagnostics Pty Ltd
Application granted granted Critical
Publication of DE69841804D1 publication Critical patent/DE69841804D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Control Of Eletrric Generators (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Vehicle Body Suspensions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69841804T 1997-09-05 1998-09-04 Diagnoseverfahren Expired - Lifetime DE69841804D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO8999A AUPO899997A0 (en) 1997-09-05 1997-09-05 A method of diagnosis
AUPP5062A AUPP506298A0 (en) 1998-08-04 1998-08-04 A method of diagnosis - II
PCT/AU1998/000723 WO1999013337A1 (en) 1997-09-05 1998-09-04 A method of diagnosis

Publications (1)

Publication Number Publication Date
DE69841804D1 true DE69841804D1 (de) 2010-09-16

Family

ID=25645598

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69841804T Expired - Lifetime DE69841804D1 (de) 1997-09-05 1998-09-04 Diagnoseverfahren

Country Status (11)

Country Link
US (1) US8097420B1 (de)
EP (1) EP1018018B1 (de)
JP (2) JP4584445B2 (de)
AT (1) ATE476662T1 (de)
CA (1) CA2303169C (de)
DE (1) DE69841804D1 (de)
DK (1) DK1018018T3 (de)
HK (1) HK1029622A1 (de)
IL (3) IL134880A0 (de)
NZ (1) NZ503175A (de)
WO (1) WO1999013337A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1286327C (zh) 1996-02-28 2006-11-22 松下电器产业株式会社 光盘重放装置及光盘记录装置
WO2004077056A1 (en) * 2003-02-27 2004-09-10 Lung Health Diagnostics Pty. Ltd. A method of diagnosis and agents useful for same
SE0203591D0 (sv) * 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
EP1522857A1 (de) * 2003-10-09 2005-04-13 Universiteit Maastricht Methode zur Feststellung des Risikos von Herzversagen in einem Individuum durch Bestimmung der Menge an Galectin-3 oder Thrombospondin-2
US7659087B2 (en) * 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
EP1845379A1 (de) * 2006-04-13 2007-10-17 F. Hoffmann-La Roche AG Mittel und Verfahren zur Differenzierung kardialer und pulmonaler Ursachen von Atemnot
EP1882945A1 (de) 2006-07-28 2008-01-30 F.Hoffmann-La Roche Ag Vorrichtungen und Verfahren zur Differentierung zwischen herz- und lungenbedingten Ursachen für akute Atemnot
EP2031397A1 (de) 2007-08-30 2009-03-04 F. Hoffmann-La Roche AG Surfactantproteine B und D bei der Unterscheidung der Ursachen für Atemnot
EP2249700B1 (de) 2008-02-07 2019-04-24 Koninklijke Philips N.V. Vorrichtung zum messen und zur vorhersage der künftigen atemstabilität
WO2012130731A1 (en) 2011-03-25 2012-10-04 Roche Diagnostics Gmbh MEASUREMENT OF C-TERMINAL proSP-B
CN102552879B (zh) * 2012-03-15 2013-11-06 北京双鹤现代医药技术有限责任公司 肺表面活性提取物与肺表面活性物质相关蛋白a的组合物、制备方法及其制药用途
EP2650684A1 (de) 2012-04-10 2013-10-16 Roche Diagniostics GmbH Diagnose auf Pro-SP-B und NT-proBNP bei Patienten mit Lungenentzündung
EP2615459A1 (de) 2012-04-27 2013-07-17 Roche Diagniostics GmbH Verfahren zur Diagnose von Distalbronchoalveolargewebeschäden in Asthma durch Erkennen von proSP-B
EP2866033A1 (de) 2013-10-23 2015-04-29 Roche Diagniostics GmbH Differenzialdiagnose von akuter Atemnot auf Basis von c-terminiertem proSP-B, KL-6 und BNP-Peptiden
GB201511207D0 (en) * 2015-06-25 2015-08-12 Xvivo Perfusion Ab Isolated organ evaluation and treatment
EP3287921B1 (de) * 2016-08-26 2020-11-04 Nxp B.V. Gesprochener pass-satz zur bestimmung der eignung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986007154A1 (en) 1985-05-31 1986-12-04 Teijin Limited Method for assaying human pulmonary surface active substance and reagent kit therefor
WO1989002075A1 (en) 1987-09-01 1989-03-09 Teijin Limited Method for assaying human lung surface active substance
JP2517696B2 (ja) * 1990-04-27 1996-07-24 帝人株式会社 肺疾患マ―カ―蛋白の測定法
AU665758B2 (en) 1991-04-26 1996-01-18 Surface Active Limited Novel antibodies, and methods for their use
DE69333283T2 (de) * 1992-06-09 2004-08-26 Yamasa Corp., Chishi Lungenkrankheiten screening durch messung der HUMANES OBERFLÄCHENAKTIVES APOPROTEIN D DER LUNGE
US5670328A (en) 1992-06-09 1997-09-23 Yamasa Corporation Monoclonal antibodies to human pulmonary surfactant apoprotein D and use thereof
JP4264199B2 (ja) 1998-07-24 2009-05-13 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 疎水性の肺界面活性剤タンパク質ｓｐ−ｃの測定
US7713705B2 (en) 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof

Also Published As

Publication number Publication date
JP2001516057A (ja) 2001-09-25
EP1018018A4 (de) 2004-12-22
IL172185A0 (en) 2009-02-11
NZ503175A (en) 2002-11-26
EP1018018B1 (de) 2010-08-04
JP2010197405A (ja) 2010-09-09
IL134880A (en) 2006-12-10
DK1018018T3 (da) 2010-11-15
IL134880A0 (en) 2001-05-20
CA2303169A1 (en) 1999-03-18
HK1029622A1 (en) 2001-04-06
EP1018018A1 (de) 2000-07-12
ATE476662T1 (de) 2010-08-15
CA2303169C (en) 2009-11-10
WO1999013337A1 (en) 1999-03-18
JP4584445B2 (ja) 2010-11-24
US8097420B1 (en) 2012-01-17

Similar Documents

Publication Publication Date Title
IL172185A0 (en) Method of diagnosis lung damage
DK1328421T3 (da) Fremgangsmåde og apparat til vurdering og forbedring af en førers arbejdspræstation
ATE316147T1 (de) Enzymsensor
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
ATE442592T1 (de) Detektion und/oder beobachtung von synuclein- assoziierten krankheiten
FI941512A0 (fi) Laitteisto ja menetelmä työstökoneen toiminnallisen tehokkuuden määrittämiseksi
DE69728585D1 (de) Mittel gegen Juckreiz
DE60218863D1 (de) Herz-lungen-überwachungsgerät
DE69404460D1 (de) Zell-test für alzheimersche krankheit
SE0101912D0 (sv) a method and an apparatus for measuring functional, residual capacity (FRC) and cardiac output (CO)
DE60322848D1 (de) System für kontinuierliche leistungstests
DE60043152D1 (de) Heilmittel für nierenkrankheiten und verfahren zum screenen selbiger
FR2842512B1 (fr) Systeme de securisation du fonctionnement des portes palieres d'un ascenseur
BR0207548A (pt) Método de controle de poeira automatizado
ATE272842T1 (de) Diagnose spongiformer encephalopathie
CA2091637A1 (en) Call Progress Monitoring
DE69508605D1 (de) Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes
WO1998041238A3 (en) Methods and kits for treating and diagnosing leiomyomas
DE60127935D1 (de) Verfahren zur diagnose der effektivität der xenotypischen antikörpertherapie
TR200001263T2 (tr) Kronik tıkayıcı solunum-yolu hastalığının teşhis ve terapötikleri
DE69532611D1 (de) Mittel zur behandlung von autoimmunkrankheiten
PT1128829E (pt) Associacao de riluzole e de alfa-tocoferol
ATE362545T1 (de) Screening-verfahren für substanzen zur behandlung von diabetes
FI951778A0 (fi) Menetelmä allergian toteamiseksi
WO2003050300A3 (en) Diagnosis and treatment of cancer